180 related articles for article (PubMed ID: 12652343)
1. Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.
Franke H; Kittner H; Grosche J; Illes P
Psychopharmacology (Berl); 2003 May; 167(2):187-94. PubMed ID: 12652343
[TBL] [Abstract][Full Text] [Related]
2. P2Y receptor expression on astrocytes in the nucleus accumbens of rats.
Franke H; Krügel U; Grosche J; Heine C; Härtig W; Allgaier C; Illes P
Neuroscience; 2004; 127(2):431-41. PubMed ID: 15262333
[TBL] [Abstract][Full Text] [Related]
3. P2 receptor-types involved in astrogliosis in vivo.
Franke H; Krügel U; Schmidt R; Grosche J; Reichenbach A; Illes P
Br J Pharmacol; 2001 Nov; 134(6):1180-9. PubMed ID: 11704637
[TBL] [Abstract][Full Text] [Related]
4. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats.
Kittner H; Krügel U; Illes P
Neuroscience; 2001; 102(2):241-3. PubMed ID: 11166110
[TBL] [Abstract][Full Text] [Related]
5. P2 receptor-mediated proliferative effects on astrocytes in vivo.
Franke H; Krügel U; Illes P
Glia; 1999 Dec; 28(3):190-200. PubMed ID: 10559778
[TBL] [Abstract][Full Text] [Related]
6. P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo.
Franke H; Sauer C; Rudolph C; Krügel U; Hengstler JG; Illes P
Glia; 2009 Aug; 57(10):1031-45. PubMed ID: 19115395
[TBL] [Abstract][Full Text] [Related]
7. Changes in purinergic signaling after cerebral injury -- involvement of glutamatergic mechanisms?
Franke H; Grummich B; Härtig W; Grosche J; Regenthal R; Edwards RH; Illes P; Krügel U
Int J Dev Neurosci; 2006; 24(2-3):123-32. PubMed ID: 16387466
[TBL] [Abstract][Full Text] [Related]
8. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo.
Krügel U; Kittner H; Franke H; Illes P
Neuropharmacology; 2001 Jun; 40(8):1084-93. PubMed ID: 11406200
[TBL] [Abstract][Full Text] [Related]
10. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors.
Ryu JK; Kim J; Choi SH; Oh YJ; Lee YB; Kim SU; Jin BK
Neuroreport; 2002 Sep; 13(13):1611-5. PubMed ID: 12352612
[TBL] [Abstract][Full Text] [Related]
11. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
12. Pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS), a putative P2Y(1) receptor antagonist, blocks signaling at a site distal to the receptor in Madin-Darby canine kidney-D(1) cells.
Shehnaz D; Torres B; Balboa MA; Insel PA
J Pharmacol Exp Ther; 2000 Jan; 292(1):346-50. PubMed ID: 10604969
[TBL] [Abstract][Full Text] [Related]
13. Blockade of P2 nucleotide receptors after spinal cord injury reduced the gliotic response and spared tissue.
Rodríguez-Zayas AE; Torrado AI; Rosas OR; Santiago JM; Figueroa JD; Miranda JD
J Mol Neurosci; 2012 Jan; 46(1):167-76. PubMed ID: 21647706
[TBL] [Abstract][Full Text] [Related]
14. ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice.
Carmo MR; Simões AP; Fonteles AA; Souza CM; Cunha RA; Andrade GM
Eur J Neurosci; 2014 Feb; 39(4):614-22. PubMed ID: 24304101
[TBL] [Abstract][Full Text] [Related]
15. P2X receptor expression on astrocytes in the nucleus accumbens of rats.
Franke H; Grosche J; Schädlich H; Krügel U; Allgaier C; Illes P
Neuroscience; 2001; 108(3):421-9. PubMed ID: 11738256
[TBL] [Abstract][Full Text] [Related]
16. Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides.
Kittner H; Franke H; Harsch JI; El-Ashmawy IM; Seidel B; Krügel U; Illes P
Eur J Neurosci; 2006 Oct; 24(7):2049-56. PubMed ID: 17067301
[TBL] [Abstract][Full Text] [Related]
17. P2 receptor expression in the dopaminergic system of the rat brain during development.
Heine C; Wegner A; Grosche J; Allgaier C; Illes P; Franke H
Neuroscience; 2007 Oct; 149(1):165-81. PubMed ID: 17869006
[TBL] [Abstract][Full Text] [Related]
18. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
Brown CA; Charlton SJ; Boarder MR
Br J Pharmacol; 1997 Mar; 120(6):1049-52. PubMed ID: 9134216
[TBL] [Abstract][Full Text] [Related]
20. P2X7 receptor expression after ischemia in the cerebral cortex of rats.
Franke H; Günther A; Grosche J; Schmidt R; Rossner S; Reinhardt R; Faber-Zuschratter H; Schneider D; Illes P
J Neuropathol Exp Neurol; 2004 Jul; 63(7):686-99. PubMed ID: 15290894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
